Artemis Medicare Services Ltd Stock Price Today (NSE: ARTEMISMED)
Fundamental Score
Artemis Medicare Services Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Artemis Medicare Services Ltd share price today is ₹205.51, down 4.33% on NSE/BSE as of 30 March 2026. Artemis Medicare Services Ltd (ARTEMISMED) is a Small-cap company in the Hospital sector with a market capitalisation of ₹4.41K (Cr). The 52-week high for ARTEMISMED share price is ₹306.15 and the 52-week low is ₹210.06. At a P/E ratio of 46.29x, ARTEMISMED is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 12.92% and a debt-to-equity ratio of 0.31.
Artemis Medicare Services Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Artemis Medicare Services Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Artemis Medicare Services Share Price: A Financial Snapshot
The healthcare landscape is undergoing a significant shift, with specialized medical services and advanced treatments becoming increasingly sought after. This analysis examines the financial position of Artemis Medicare Services Ltd, focusing on its industry performance. The current Artemis Medicare Services share price is ₹217.330002, and its Price-to-Earnings (PE) ratio stands at 46.29. This financial snapshot is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, offering an objective perspective on the company's standing.
The company's PE ratio of 46.29 suggests that investors are paying a premium for each rupee of earnings, potentially indicating high growth expectations. Comparing Artemis Medicare Services Ltd. with sector peers provides a clearer picture. While a direct comparison with
Nephro Care India Limited on management quality requires deeper qualitative analysis, a relative PE analysis can be informative. If Nephro Care India Limited demonstrates superior operational efficiency and strategic vision reflected in a lower PE ratio, it might suggest a more compelling valuation from a management effectiveness perspective.Artemis Medicare Services Ltd reports a Return on Capital Employed (ROCE) of 14.88%. This metric indicates the efficiency with which the company is generating profits from its capital investments. A higher ROCE generally signifies a stronger competitive advantage or "moat." In Artemis's case, 14.88% ROCE shows a decent level of capital efficiency. If consistently maintained or improved, this could translate into a sustainable competitive edge within its specific niche of the hospital services sector. This consistent return on capital empowers the company to reinvest in infrastructure, advanced technologies, and attract skilled professionals, contributing to the moat's strengthening.
Considering the competitive landscape, a thorough examination of Artemis Medicare Services Ltd's financial health, operational performance, and management effectiveness is crucial for understanding the long-term prospects of its share price. Observing these trends relative to competitors like Strategic Minerals Plc and Abateas Industries Ltd provides a more nuanced understanding of Artemis's position within the market.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Artemis Medicare Services Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ARTEMISMED across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Robust Profit Growth (32.80%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (31.44% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (32.46% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (5.31x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹33.75 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (58.43%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 46.29x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Share Pledging Risk (44.53%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
Artemis Medicare Services Ltd Financial Statements
Comprehensive financial data for Artemis Medicare Services Ltd including income statement, balance sheet and cash flow
About ARTEMISMED (Artemis Medicare Services Ltd)
Artemis Medicare Services Ltd is a prominent healthcare provider, weaving a tapestry of medical expertise across its network of hospitals. Each facility is a hub of advanced techno...logy and compassionate care, designed to cater to a diverse range of medical needs. From intricate surgical procedures to comprehensive medical management, Artemis hospitals are equipped with state-of-the-art diagnostic tools and treatment modalities. They foster an environment of healing, where patient well-being is at the heart of every endeavor. Artemis remains committed to fostering excellence and setting new standards in the delivery of healthcare services. Beyond the core medical and surgical interventions, Artemis Medicare Services Ltd emphasizes holistic patient care, recognizing the interconnectedness of physical and emotional well-being. Patients and their families benefit from a comprehensive suite of support services. This includes specialized programs like emotional support and counseling, nutritional guidance, and even childcare facilities, easing the burden on families during challenging times. Multilingual medical interpreters facilitate effective communication for international patients, ensuring a seamless and comfortable experience. Artemis proactively promotes a patient-centric approach by actively involving patients and their families in the decision-making process through advisory councils. The Artemis Medicare Services Ltd commitment to excellence is further demonstrated through cutting-edge initiatives like telemedicine and patient portals. These innovations improve accessibility to healthcare. Patients can effortlessly schedule appointments, access their medical records, and communicate with healthcare professionals remotely. The focus on continuous innovation allows Artemis to extend its reach and cater to a growing number of patients across India and internationally. Artemis Medicare strives to provide accessible, affordable, and high-quality healthcare to all.
Company Details
Key Leadership
Corporate Events
ARTEMISMED Share Price: Frequently Asked Questions
What is the current share price of Artemis Medicare Services Ltd (ARTEMISMED)?
As of 30 Mar 2026, 12:07 pm IST, Artemis Medicare Services Ltd share price is ₹205.51. The ARTEMISMED stock has a market capitalisation of ₹4.41K (Cr) on NSE/BSE.
Is ARTEMISMED share price Overvalued or Undervalued?
ARTEMISMED share price is currently trading at a P/E ratio of 46.29x, compared to the industry average of 52.84x. Based on this relative valuation, the Artemis Medicare Services Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of ARTEMISMED share price?
The 52-week high of ARTEMISMED share price is ₹306.15 and the 52-week low is ₹210.06. These values are updated daily from NSE/BSE price data.
What factors affect the Artemis Medicare Services Ltd share price?
Key factors influencing ARTEMISMED share price include quarterly earnings growth (Sales Growth: 14.96%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Artemis Medicare Services Ltd a good stock for long-term investment?
Artemis Medicare Services Ltd shows a 5-year Profit Growth of 32.46% and an ROE of 12.92%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.31 before investing in ARTEMISMED shares.
How does Artemis Medicare Services Ltd compare with its industry peers?
Artemis Medicare Services Ltd competes with major peers in the Hospital. Investors should compare ARTEMISMED share price P/E of 46.29x and ROE of 12.92% against the industry averages to determine competitive standing.
What is the P/E ratio of ARTEMISMED and what does it mean?
ARTEMISMED share price has a P/E ratio of 46.29x compared to the industry average of 52.84x. Investors pay ₹46 for every ₹1 of annual earnings.
How is ARTEMISMED performing according to Bull Run's analysis?
ARTEMISMED has a Bull Run fundamental score of 41/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ARTEMISMED belong to?
ARTEMISMED operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Artemis Medicare Services Ltd share price.
What is Return on Equity (ROE) and why is it important for ARTEMISMED?
ARTEMISMED has an ROE of 12.92%, which shows decent profitability but room for improvement. ROE measures how efficiently Artemis Medicare Services Ltd generates profits from shareholders capital.
How is ARTEMISMED debt-to-equity ratio and what does it indicate?
ARTEMISMED has a debt-to-equity ratio of 0.31, which indicates moderate leverage that should be monitored.
What is ARTEMISMED dividend yield and is it a good dividend stock?
ARTEMISMED offers a dividend yield of 0.16%, meaning you receive ₹0.16 annual dividend for every ₹100 invested in Artemis Medicare Services Ltd shares.
How has ARTEMISMED share price grown over the past 5 years?
ARTEMISMED has achieved 5-year growth rates of: Sales Growth 10.15%, Profit Growth 32.46%, and EPS Growth 31.44%.
What is the promoter holding in ARTEMISMED and why does it matter?
Promoters hold 58.43% of ARTEMISMED shares, with 44.53% pledged. High promoter holding often indicates strong management confidence in Artemis Medicare Services Ltd.
What is ARTEMISMED market capitalisation category?
ARTEMISMED has a market capitalisation of ₹4414 crores, placing it in the Small-cap category.
How volatile is ARTEMISMED stock?
ARTEMISMED has a beta of N/A. A beta > 1 suggests the Artemis Medicare Services Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ARTEMISMED operating profit margin trend?
ARTEMISMED has a 5-year average Operating Profit Margin (OPM) of 13.90%, indicating the company's operational efficiency.
How is ARTEMISMED quarterly performance?
Recent quarterly performance shows Artemis Medicare Services Ltd YoY Sales Growth of 14.96% and YoY Profit Growth of 32.80%.
What is the institutional holding pattern in ARTEMISMED?
ARTEMISMED has FII holding of 12.48% and DII holding of 3.35%. Significant institutional holding often suggests professional confidence in the Artemis Medicare Services Ltd stock.